KLEMP WALTER V (CEO and President) exercised options at MOLECULIN BIOTECH, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 7/5/2023ACC: 0001437749-23-019412
DirectorOfficer· CEO and President
Since Jul 2019
-3.58K
Net shares
Net seller
$2.1K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
14.72K acquired · 18.30K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+14.72K
Price / share
—
Trade value
—
% of position
3.1%
7/2/2023
471.36K→486.07K
Common Stock
Direct
Shares
−3.58K
Price / share
$0.58
Trade value
$2.07K
% of position
0.7%
7/2/2023
486.07K→482.49K
Total
Net shares
+11.13K
Net value
-$2.07K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/2/2023 | M · Option Exercise | +14.72K | — | — | 3.1% | 471.36K | 486.07K |
| Common Stock Direct | 7/2/2023 | F · Tax Withholding | −3.58K | $0.58 | $2.07K | 0.7% | 486.07K | 482.49K |
| Total | +11.13K | -$2.07K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
14.72K shares
Shares
−14.72K
Strike price
Held after
1.94M
Exercisable
—
7/2/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock14.72K shares | 7/2/2023 | M · Option Exercise | −14.72K | — | 1.94M |